Eye drops recalled nationwide due to labeling mix-up
AvKARE is recalling Polyvinyl Alcohol Ophthalmic Solution eye drops due to a labeling mix-up. The recall affects Lot #0160 and was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall involving a labeling error (label mix-up). FDA Class III recalls are the least serious category. With no reported illnesses or injuries and only a labeling issue, this constitutes a minor labeling error corresponding to Score 2 (Moderate) per the severity rubric.
Plain-English summary
AvKARE is recalling Polyvinyl Alcohol Ophthalmic Solution 1.4% (moisturizing lubricant eye drops) in 0.5 FL OZ (15 mL) bottles due to a labeling mix-up. The recall affects product from Lot #0160 with an expiration date of April 26, 2026. The product was distributed nationwide throughout the United States.
The U.S. Food and Drug Administration classified this as a Class III recall, indicating the lowest severity category for drug recalls.
The recalled product
- Product
- POLYVINYL ALCOHOL (POLYVINYL ALCOHOL)
- Brand
- POLYVINYL ALCOHOL
- Manufacturer
- AvKARE
- Category
- Drug — Ophthalmic
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 0160
- Exp. Date April 26 2026
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by AvKARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · POLYVINYL ALCOHOL
- SeverePolyvinyl Alcohol Eye Drops Recalled for Manufacturing and Sterility Issues
FDA (Drugs) · 2025-05-14
Same manufacturer · AvKARE
See all →- HighAmantadine hydrochloride capsules recalled after failing dissolution specifications
FDA (Drugs) · 2026-03-04
- ModerateRosuvastatin tablets recalled after failing a dissolution specification
FDA (Drugs) · 2026-01-14
- HighOral contraceptive tablets recalled after failing content uniformity specifications
FDA (Drugs) · 2025-10-15
- HighAvKare chlorpromazine 100 mg cartons recalled over presence of foreign substance
FDA (Drugs) · 2025-09-17
- HighAvKare chlorpromazine unit dose cartons recalled over presence of foreign substance
FDA (Drugs) · 2025-09-17
Same hazard · label mix up
See all →- HighAmphetamine extended-release capsules contain immediate-release pellets after label mix-up
FDA (Drugs) · 2026-07-08
- SevereBuffered penicillin G potassium vials may actually contain cefazolin for injection
FDA (Drugs) · 2025-07-09
- SevereSandoz cefazolin cartons contained vials labeled as penicillin G potassium
FDA (Drugs) · 2025-07-09
- HighPrescription Drug Sunitinib Malate Subject to Label Mix-Up Recall
FDA (Drugs) · 2024-12-11
- HighSunitinib Malate Capsules Recalled Due to Label Mix-Up
FDA (Drugs) · 2024-12-11